PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

191 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
141.
Tobollik, S. et al.: Epstein-barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth. Blood 108, 3859-3864 (2006)
142.
Adam, C. et al.: DC-NK cell cross talk as a novel CD4⁺ T-cell-independent pathway for antitumor CTL induction. Blood 106, 338-344 (2005)
143.
Bagrintseva, K. et al.: FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L). Blood 105, 3679-3685 (2005)
144.
Coriu, D.* et al.: A molecular basis for nonsecretory myeloma. Blood 104, 829-831 (2005)
145.
Grimm, T. et al.: EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood 105, 3263-3269 (2005)
146.
Kohl, T.M. ; Schnittger, S. ; Ellwart, J.W. ; Hiddemann, W.* & Spiekermann, K.: KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor. Blood 105, 3391 (2005)
147.
Kurschus, F.C.* ; Bruno, R.* ; Fellows, E.* ; Falk, C.S. & Jenne, D.*: Membrane receptors are not required to deliver granzyme B during killer cell attack. Blood 105, 2049-2058 (2005)
148.
Mancao, C. ; Altmann, M. ; Jungnickel, B. & Hammerschmidt, W.: Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. Blood 106, 4339-4344 (2005)
149.
Mayr, C. et al.: Fibromodulin as a novel tumor-associated antigen (TAA)in chronic lymphocytic leukemia (CLL) which allows expansion of specific CD8+ autologous T lymphocytes. Blood 105, 1566-1573 (2005)
150.
Mayr, C. et al.: Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107, 742-751 (2005)
151.
Mayr, C. et al.: Transduction fo CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells. Blood 106, 3223-3226 (2005)
152.
Pagés, F.* et al.: Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells. Blood 105, 1632-1639 (2005)
153.
Bagrintseva, K. et al.: Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoitic cells. Blood 103, 2266-2275 (2004)
154.
Baran-Marszak, F.* et al.: Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 104, 2475-2483 (2004)
155.
Massberg, S.* et al.: Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood 103, 136-142 (2004)
156.
Pfister, H.* et al.: Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104, 1411-1418 (2004)
157.
Specht, K. et al.: Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 104, 1120-1126 (2004)
158.
Katzenberger, T.* et al.: Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell. Blood 101, 699-702 (2003)
159.
Kolb, H.-J. ; Schmid, C. ; Barrett, A.J.* & Schendel, D.J.: Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103, 767-776 (2003)
160.
Quintanilla-Martinez, L. et al.: Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL) : Implications for pathogenesis. Blood 101, 3181-3187 (2003)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... ▶▶ ▶▮